Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kiora Pharmaceuticals's enterprise value was -$10.86M on Nov 11, 2026, against -$12.58M a year earlier. Over the last 5 years it ranged from -$19.26M to $148.38M, with a median of -$3.88M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$10.86M | – |
| 2025 | Dec 31, 2025 | -$12.62M | – |
| 2024 | Dec 31, 2024 | -$19.14M | – |
| 2023 | Dec 29, 2023 | -$1.39M | -101.0% |
| 2022 | Dec 30, 2022 | $143.20M | +1825.0% |
| 2021 | Dec 31, 2021 | $7.44M | -62.0% |
| 2020 | Dec 31, 2020 | $19.56M | -28.1% |
| 2019 | Dec 31, 2019 | $27.18M | -90.5% |
| 2018 | Dec 31, 2018 | $285.74M | +9.8% |
| 2017 | Dec 29, 2017 | $260.14M | +16.7% |
| 2016 | Dec 30, 2016 | $222.97M | -24.9% |
| 2015 | Dec 31, 2015 | $297.01M | – |
See a number that looks wrong?